March 14-16, 2017 | Boston, MA

 

ICI Boston is the annual event that unites pioneering the drug developers who have successfully developed and implemented IO monotherapies and combinations.

Focused exclusively on identifying clinically effective combinations, validating patient selection biomarkers and assessing novel target pathways, ICI Boston is the only forum to provide a balanced and comprehensive insight into the development of the next generation of IO therapeutic strategies.

Join the leaders in the field and leave with key insights that will enable you to make the right decisions with your IO pipeline to lay the foundations for future success.

Register your interest here

 

 

 

Hear What Previous ICI Boston Attendees Have To Say:

‘Great Meeting, very informative, great to see what other companies are working on in the field of cancer immunotherapy.’ Genentech

‘I took away a lot of information and really enjoyed the conference…..I learned a lot and enjoyed it.’ Merck

‘Great meeting for an over-view on the iONC landscape. I enjoyed the versatility of the talks and the opportunity to network with peers.’ EMD Serono

Past Attendees Included:
spex-logos-info-2
Immunotherapy News Widget-smal